Skip to main content
. 2022 Mar 7;12:863057. doi: 10.3389/fonc.2022.863057

Figure 1.

Figure 1

Number of patients with a mutation found on ALK, BRAF, EGFR, ERBB2, KRAS and MET genes according on the technic used: hotspot analysis (white), in-house panel (light grey), commercial panel (dark grey), or exome analysis (black).